CollPlant Holdings Ltd. Form 6-K Summary
Business Context and Reporting Period
This Form 6-K was filed by CollPlant Holdings Ltd. on May 28, 2019, covering the month of May 2019. The registrant is a foreign private issuer based in Rehovot, Israel, and files annual reports on Form 20-F.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report serves solely to disseminate a press release and does not contain audited or unaudited financial statements.
Material Changes
No material financial changes versus prior periods are reported in this document. The filing focuses on a corporate development regarding the company's technology presentation.
Outlook, Commentary, and Risks
The primary content of this filing is the incorporation by reference of a press release (Exhibit 99.1). The press release announces that CollPlant presented its rhCollagen-based BioInks for the 3D bioprinting of tissues and organs at the TERMIS Annual Meeting in Rhodes, Greece. The filing does not contain specific management guidance, risk factors, or details on contingencies beyond the context of this presentation.
Key Facts for Investor Verification
- The filing is a non-financial report designed to distribute a press release regarding a scientific presentation.
- CollPlant showcased rhCollagen-based BioInks for 3D bioprinting at the TERMIS Annual Meeting in May 2019.
- No financial performance data is included in this specific Form 6-K; investors should refer to the most recent Form 20-F for financial metrics.
- The report was signed by Eran Rotem, Deputy CEO and Chief Financial Officer.